Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Pharmaceutical Preparations · Tokyo, JP · filing with the SEC since 2007
Who owns Takeda Pharmaceutical Company Limited
As filed with the SECHolders of 5% or more
0
No Schedule 13D or 13G naming this company is on file.
Directors and officers
31
report now, of 31 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 0 named at left.
Holders of 5% or moreshare of the class, as filed
No holder of 5% or more is on file in a Schedule 13D or 13G naming this company.
What TAK reports owning in othersstakes of 5% or more, and other ties
Ovid Therapeutics Inc. OVID
SCHEDULE 13G/A · filed Dec 9, 2025 · Common Stock, par value $0.001 per share
Hillevax, Inc.
SCHEDULE 13D/A · filed Sep 19, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%
Its Form 13F-HR for Sep 30, 2025 lists 8 holdings. The record carries no value for them.
Insider tradesForm 4
22sales
0purchases
2sales on a scheduled plan
13people selling
$15.2Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 5, 2025 to Nov 5, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 5, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window13 of 31 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Plump Andrew Stewart | President, R&D | 3 | $5.3M | 2 | 0 | $0 |
| Bitetti Teresa Marie | President, OBU | 2 | $1.8M | 0 | 0 | $0 |
| Platford Giles Richard | President, IBU | 2 | $1.7M | 0 | 0 | $0 |
| Kim Julie So-Young | President and CEO | 1 | $1.5M | 0 | 0 | $0 |
| Duprey Lauren Rusckowski | Chief Transformation Officer | 2 | $1.5M | 0 | 0 | $0 |
| Greenway Nicola Deidre Petal | Chief Human Resources Officer | 4 | $1.0M | 0 | 0 | $0 |
| Furney Natalie Anne Marie | Global General Counsel | 1 | $500,000 | 0 | 0 | $0 |
| Ricci Gabriele | Chief Data & Tech. Officer | 1 | $400,000 | 0 | 0 | $0 |
| Pignagnoli Agosti Marcello | Head, Strat. & Port. Dev | 1 | $400,000 | 0 | 0 | $0 |
| Shannon Elaine Mary | Pres., Global Supply & Quality | 2 | $400,000 | 0 | 0 | $0 |
| Pacheco Rhonda Janice | President, U.S. Business Unit | 1 | $300,000 | 0 | 0 | $0 |
| Farajallah Awny Samaan Botros | Chief Medical Officer | 1 | $200,000 | 0 | 0 | $0 |
| Ibrahim Ramy Riad Ahmed | President, PDT BU | 1 | $100,000 | 0 | 0 | $0 |